{"product_id":"emerging-viral-threats-in-pregnancy-hantavirus-ebola-lcmv-oropouche-mpox-and-other-high-consequence-pathogens-a-2026-clinical-reference-for-mate-9798198535572","title":"Emerging Viral Threats in Pregnancy: Hantavirus, Ebola, LCMV, Oropouche, Mpox and Other High-Consequence Pathogens: A 2026 Clinical Reference for Mate","description":"\u003cp\u003e • Author(s): Olivier Ami\u003cbr\u003e • Publisher: Independently Published\u003cbr\u003e • Publisher Imprint: Independently Published\u003cbr\u003e • BISAC: Diagnosis\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis comprehensive 2026 clinical reference provides maternal-fetal medicine specialists, obstetricians, infectious disease physicians, and perinatal teams with an authoritative, evidence-based guide to the diagnosis, management, and prevention of emerging and high-consequence viral infections in pregnancy.\u003c\/p\u003e\u003cp\u003eCovering 18 key pathogens - ranked by an original \u003cb\u003eComposite Obstetric Severity Score\u003c\/b\u003e that integrates maternal (�0.4) and fetal\/neonatal (�0.6) risk - the book addresses Lassa fever, Nipah, Ebola\/Marburg (score 5.0), Oropouche, Mpox clade Ib, Hantavirus, LCMV, Rift Valley Fever, and other critical threats, alongside well-established pathogens such as CMV, Zika, Parvovirus B19, Dengue, Chikungunya, Influenza\/COVID-19, West Nile, and TBE.\u003c\/p\u003e\u003cp\u003eEach pathogen chapter follows a standardized 10-section structure optimized for rapid clinical decision-making at the point of care, including epidemiologic data (US, Canadian, European, and global), virology and transmission, clinical presentation, laboratory diagnosis, treatment in pregnancy, delivery and breastfeeding management, and preconception counseling. A unique 6-tier evidence labeling system clearly distinguishes established data, concerning signals, expert consensus, and areas where data remain unavailable as of May 2026.\u003c\/p\u003e\u003cp\u003eThe book integrates the latest ACOG, SMFM, CDC, PHAC, NACI, SOGC, WHO, ECDC, and PAHO guidance while incorporating high-quality French and European obstetric cohort data often absent from North American references. Practical tools include decision algorithms, Master Tables for quick reference, and dedicated sections on the pregnant febrile traveler, obstetric sepsis, maternal immunology, and diagnostic stewardship.\u003c\/p\u003e\u003cp\u003eEssential reading for any clinician managing pregnant patients with travel history, occupational exposure, or suspected emerging viral infection in 2026 and beyond.\u003c\/p\u003e","brand":"Independently Published","offers":[{"title":"Paperback","offer_id":47890483839127,"sku":"9798198535572","price":7457.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9798198535572.webp?v=1781180204","url":"https:\/\/atlanticbooks.com\/products\/emerging-viral-threats-in-pregnancy-hantavirus-ebola-lcmv-oropouche-mpox-and-other-high-consequence-pathogens-a-2026-clinical-reference-for-mate-9798198535572","provider":"Atlantic Books","version":"1.0","type":"link"}